High expression of G6PD increases doxorubicin resistance in triple negative breast cancer cells by maintaining GSH level

High expression of G6PD increases doxorubicin resistance in triple negative breast cancer cells by maintaining GSH level

Resistance to doxorubicin (DOX) remains a big challenge to breast cancer treatment especially for triple negative breast cancer (TNBC). Our previous study revealed that the antioxidant system plays an important role in conferring metastasis derived DOX resistance. In this study, we used two-dimensio...

Full description

Bibliographic Details
Main Authors: Luo, Man, Fu, Afu, Wu, Renfei, Wei, Na, Song, Kai, Lim, Sierin, Luo, Kathy Qian
Other Authors: Interdisciplinary Graduate School (IGS)
Format: Journal Article
Language:English
Published: 2022
Subjects:
Engineering::Bioengineering
Triple Negative Breast Cancer
Metastasis
Online Access:https://hdl.handle.net/10356/161346

Internet

https://hdl.handle.net/10356/161346

Similar Items